Friday, April 24, 2026 | 04:05 PM ISTहिंदी में पढें
Sandu Pharmaceuticals Ltd
Board Meeting Intimation for 1. To Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2023.2. To Consider/Recommend Dividend For The Financial Year 2022-23.3. Any Other Matter With The Permi
03:55 PM, 4th Aug 2023
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. To Approve Unaudited standalone and consolidated Financial Results of the Company for the Quarter ended 30th June 2023.2. To consider/recommend Dividend for the Financial Year 2022-23.3. Any other matter with the permission of Chairman.